Artiva Biotherapeutics In...

AI Score

0

Unlock

3.86
-0.29 (-6.99%)
At close: Mar 03, 2025, 3:59 PM
3.92
1.55%
After-hours: Mar 03, 2025, 04:00 PM EST

Artiva Biotherapeutics Income Statement

Year FY23 FY22 FY21 FY20
Revenue 33.49M 4.93M 2M n/a
Cost of Revenue n/a n/a n/a n/a
Gross Profit 33.49M 4.93M 2M n/a
Operating Income -30.67M -59.83M -53.27M -18.27M
Interest Income 2.54M 1.29M n/a 2K
Pretax Income -27.62M -58.34M -71.83M -17.99M
Net Income -27.7M -58.39M -71.83M -17.99M
Selling & General & Admin 13.91M 20.78M 12.86M 4.43M
Research & Development 50.25M 43.98M 42.41M 13.85M
Other Expenses n/a 200K -18.55M 477K
Operating Expenses 64.16M 64.76M 55.27M 18.27M
Interest Expense n/a n/a n/a 199K
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 64.16M 64.76M 55.27M 18.27M
Income Tax 72K 53K -18.55M 676K
Shares Outstanding (Basic) 9.35M 17.58M 17.58M 17.58M
Shares Outstanding (Diluted) 9.35M 17.58M 17.58M 17.58M
EPS (Basic) -2.96 -3.32 -4.08 -1.02
EPS (Diluted) -2.96 -3.32 -4.08 -1.02
EBITDA -28.41M -58.67M -71.58M -17.72M
Depreciation & Amortization 2.27M 1.16M 248K 73K